Successful Intravenous Immunoglobulin Therapy in 3 Cases of Parvovirus B19-Associated Chronic Fatigue Syndrome.
Kerr JR et al. (2003) Successful Intravenous Immunoglobulin Therapy in […]
Research Papers
Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.
Kogelnik AM et al. (2006) Use of valganciclovir in patients
A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain.
Lane RJM et al. (1986) A double-blind, placebo-controlled, crossover study
Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study.
Leong KH et al. (2022) Treatments of chronic fatigue syndrome
New cardiomyopathy: Pilot study of intravenous ganciclovir in a subset of the chronic fatigue syndrome.
Lerner AM et al. (1997) New cardiomyopathy: Pilot study of
A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.
Lerner AM et al. (2002) A six-month trial of valacyclovir
Individualizing medical treatment in chronic fatigue syndrome/ myalgic encephalomyelitis: Evidence for effective medications and possible relevance to “Long-Hauler Syndrome” in Covid-19 affected patients.
Levine PH et al. (2022) Individualizing medical treatment in chronic
A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.
Lloyd A et al. (1990) A double-blind, placebo-controlled trial of
Immunologic and psychologic therapy for patients with chronic fatigue syndrome: A double-blind, placebo-controlled trial.
Lloyd A et al. (1993) Immunologic and psychologic therapy for
Abnormalities of carnitine metabolism in chronic fatigue syndrome.
Abnormalities of carnitine metabolism in chronic fatigue syndrome. Read More »
Majeed T et al. (1995) Abnormalities of carnitine metabolism in
A comparative study of valaciclovir, valganciclovir, and artesunate efficacy in reactivated HHV-6 and HHV-7 infections associated with chronic fatigue syndrome/myalgic encephalomyelitis.
Maltsev D (2022) A comparative study of valaciclovir, valganciclovir, and
Low-dose hydrocortisone for treatment of chronic fatigue syndrome: A randomized controlled trial.
McKenzie R et al. (1998) Low-dose hydrocortisone for treatment of
Modafinil: serious skin reactions, hypersensitivity, and psychiatric symptoms.
Modafinil: serious skin reactions, hypersensitivity, and psychiatric symptoms. Read More »
Medicines and Healthcare Products Regulatory Agency. (2008) Modafinil: serious skin
4.15 Cardiac rhythm disorders – QT interval prolongation.
4.15 Cardiac rhythm disorders – QT interval prolongation. Read More »
Medicines and Healthcare Products Regulatory Agency . (2015) 4.15 Cardiac
Effect of galantamine hydrobromide in chronic fatigue syndrome: A randomized controlled trial.
Blacker C et al. (2004) Effect of galantamine hydrobromide in
Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study.
Blockmans D et al. (2003) Combination therapy with hydrocortisone and
Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?
Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome? Read More »
Blockmans D et al. (2006) Does Methylphenidate Reduce the Symptoms
Low-dose naltrexone as a treatment for chronic fatigue syndrome.
Low-dose naltrexone as a treatment for chronic fatigue syndrome. Read More »
Bolton MJ et al. (2020) Low-dose naltrexone as a treatment
Use of amantadine for chronic fatigue syndrome.
Use of amantadine for chronic fatigue syndrome. Read More »
Bowman MA et al. (1997) Use of amantadine for chronic